Presence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients.
about
Myeloid cells in circulation and tumor microenvironment of breast cancer patientsPrognostic impact of circulating Her-2-reactive T-cells producing pro- and/or anti-inflammatory cytokines in elderly breast cancer patients.Immune profiles of elderly breast cancer patients are altered by chemotherapy and relate to clinical frailtyHigh immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy.A clinical and biological perspective of human myeloid-derived suppressor cells in cancer.Does Regular Exercise Counter T Cell Immunosenescence Reducing the Risk of Developing Cancer and Promoting Successful Treatment of Malignancies?Prognostic impact of high levels of circulating plasmacytoid dendritic cells in breast cancer.CD14+ HLA-DR-/low MDSCs are elevated in the periphery of early-stage breast cancer patients and suppress autologous T cell proliferation.Parity improves anti-tumor immunity in breast cancer patients.Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, December 5th 2015.Immune correlates of clinical outcome in melanoma.Focal Irradiation And Systemic Transforming Growth Factor β Blockade in Metastatic Breast Cancer.Peripheral T cell responses to tumour antigens are associated with molecular, immunogenetic and cellular features of breast cancer patients.The impact of PI3K inhibitors on breast cancer cell and its tumor microenvironment.Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studiesImmune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse of Triple Negative Breast Cancer
P2860
Q33729434-3BC24121-DDB8-4F3C-ABD1-2F20EE564C23Q36198776-F254BCB9-90E3-456F-B2D4-E009CD23DA09Q37671301-461C197D-15D3-4B8F-92E6-A7DCA94816F4Q38748299-4A7BDCF2-0C2A-48FB-9268-32CC3BBDB7C5Q38847251-DC81206C-56FF-4051-8C94-311A099AF2DDQ40104771-806EEF28-788D-44B8-B4D2-DEBEB33EFCCCQ42753871-51D7596A-BD3D-461D-9FE4-2D82C3DC1F6DQ46243184-747594D9-FAC0-4D43-969B-C44BAC213FC2Q47124660-88167C5B-439A-4B8C-865E-FE0EB6F71B40Q47130393-9B158DB4-83A6-4EE2-9874-100F3F4CCE3EQ48257119-499DF3D3-0A8F-4955-9843-3AE7C04351E6Q50534906-715042E4-A8AD-49E5-A761-96C4AE4A1349Q51359999-466B4BD4-3FA3-482A-A981-C8D23538D1B2Q55435506-4B63DB91-0AD3-468C-9591-04B9EC1259DEQ57138311-B580C6A1-CE77-4773-97DD-FE17D49B6CECQ58750668-A595BFD2-0714-479C-B4AE-4C54AAE68E67
P2860
Presence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Presence of circulating Her2-r ...... older breast cancer patients.
@ast
Presence of circulating Her2-r ...... older breast cancer patients.
@en
type
label
Presence of circulating Her2-r ...... older breast cancer patients.
@ast
Presence of circulating Her2-r ...... older breast cancer patients.
@en
prefLabel
Presence of circulating Her2-r ...... older breast cancer patients.
@ast
Presence of circulating Her2-r ...... older breast cancer patients.
@en
P2093
P2860
P1476
Presence of circulating Her2-r ...... older breast cancer patients.
@en
P2093
Brigitte Gueckel
Evelyna Derhovanessian
Graham Pawelec
Jithendra Kini Bailur
P2860
P2888
P356
10.1186/S13058-015-0541-Z
P577
2015-03-10T00:00:00Z
P5875
P6179
1012586155